Pharma-Bio Serv Q1 revenue down 44% to $2.4M; swings to net loss of $270.7K

Pharma-Bio Serv, Inc.

2025-Q1 EPS reported -$0.01 revenue$2,380,187

Revenue for Q1 ended Jan 31, 2024: $2.4M, down $1.9M from $4.3M in prior-year quarter.
Net loss of ~$270.7K vs net income of $426.4K in the same quarter last year.
CEO cites planned investments in business development to drive future growth and profitability.
No specific financial guidance or outlook provided for fiscal year 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Pharma-Bio Serv, Inc. reported the quarter ended January 31, 2024 results: revenue approximately $2.4 million, net income approximately $270,700.

Period: the quarter ended January 31, 2024
Revenue: approximately $2.4 million
Net income: approximately $270,700
Result: reported results

Exact text from the filing

today announced that revenues for the quarter ended January 31, 2024 were approximately $2.4 million, a decrease of approximately $1.9 million when compared to the same period last year. Net loss for the quarter ended January 31, 2024 was approximately $270,700 compared to a net income of approximately $426,400 for the same period last year.

View on SEC.gov

308 earnings releases filed in the last 30 days. Browse all earnings releases →

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-24-003318

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.